RESEARCH, PHARMACY MARKET

IP Outlook 2023 - Patent Decisions Affecting Pharma and Biotech Companies

February 2, 2023

IP Outlook 2023 - Patent Decisions Affecting Pharma and Biotech Companies

Spotlight

Denovo Biopharma

A Novel Biomarker Discovery Solution for Personalized Drug Development. Denovo Biopharma is a private San Diego based biotech company, also operating in China, providing a novel biomarker solution to personalize drug development. The core technology of the company is its industry's first platform and algorithm to perform de novo genomic biomarker discovery retrospectively using archived clinical samples.

OTHER VIDEOS

Forecasting & Future of Pharmaceutical Industry

video | March 24, 2023

It’s time to know the future of Pharmaceutical Industry & that’s why Odyx yHat forecasts! Today, we have entered into a new space where data is fuel to the world and time series forecasting is a strategy to mold it into influential insights....

Watch Now

How to Prepare for an FDA Pre-Approval Inspection

video | March 23, 2023

You don't GET inspection ready, you have to BE inspection ready." Redica Systems Sales Manager, Sam McDonald, shows you how to prepare for an #FDA pre-approval inspection....

Watch Now

How To Avoid Pharmaceutical Data Analysis Errors Based on Unnormalized Data Sets

video | March 23, 2023

Redica Systems Senior #GMP Quality Expert, Jerry Chapman, debunks a common misconception about #pharmaceutical recall data and shows you how to avoid making analysis errors based on raw (unnormalized) #FDA data....

Watch Now

How does TRxA Help Bridge the Drug Development "Valley of Death?"

video | March 22, 2023

Drug development has several phases that are categorized as discovery (preclinical), development (clinical trials), and commercialization, once approved by regulatory agencies such as the U.S. Food and Drug Administration....

Watch Now

Spotlight

Denovo Biopharma

A Novel Biomarker Discovery Solution for Personalized Drug Development. Denovo Biopharma is a private San Diego based biotech company, also operating in China, providing a novel biomarker solution to personalize drug development. The core technology of the company is its industry's first platform and algorithm to perform de novo genomic biomarker discovery retrospectively using archived clinical samples.

Events